Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
J Biochem Mol Toxicol ; 37(7): e23372, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37102204

ABSTRACT

Cis-diamminedichloroplatinum (II) (cisplatin, Cis) is widely employed to treat several types of cancer. It has many important toxic side effects; one of the most important of which is nephrotoxicity. Clemizole hydrochloride (Clem) as the most potent inhibitor of TRPC5 channels was tested in an animal model of Cis-induced nephrotoxicity. Rats were divided into the following groups: control; Cis (8 mg/kg); Cis + 1 mg/kg Clem; Cis + 5 mg/kg Clem; Cis + 10 mg/kg Clem. Kidney injury was detected by histopathological and biochemical analysis. Urine urea nitrogen (UUN), creatinine, urine neutrophil gelatinase-associated lipocalin (NGAL), serum catalase (CAT), and malondialdehyde (MDA) levels were determined by enzyme-linked immunosorbent assay. Total antioxidant status (TAS) and total oxidant status (TOS) were studied using a colorimetric assay. Nephrin, synaptopodin, and Rac family small GTPase 1 (RAC1) expressions were detected by Western blot analysis. Cis was found to induce histopathological alterations, including tubular degeneration, congestion, hemorrhage, hyaline casts, glomerular collapse, and apoptotic cell death. Clem at a dose of 1 and 5 mg/kg attenuated histopathological alterations. UUN, creatinine, and NGAL levels increased in the Cis-administered group, while all doses of Clem decreased in those. CAT and TAS levels decreased, while TOS and oxidative stress index levels increased in the Cis-treated group. A dose of 1 and 5 mg Clem showed antioxidant effects against oxidative stress. Cis induced lipid peroxidation by increasing MDA levels. All doses of Clem reduced MDA levels. Nephrin and synaptopodin expressions were decreased by Cis, and all doses of Clem increased that. All doses of Clem successfully depressed RAC1 expression. Clem showed a highly ameliorating effect on toxicity caused by Cis by blocking TRPC5 calcium channels.


Subject(s)
Cisplatin , Renal Insufficiency , Rats , Animals , Cisplatin/toxicity , Lipocalin-2/metabolism , Lipocalin-2/pharmacology , Creatinine , Kidney , Renal Insufficiency/chemically induced , Antioxidants/pharmacology , Antioxidants/metabolism , Oxidative Stress , Urea , TRPC Cation Channels/metabolism
2.
Biol Trace Elem Res ; 179(1): 110-116, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28168533

ABSTRACT

Growth hormone (GH) and zinc (Zn) were evaluated for their potential to prevent radiation injury using a rat model of radiation-induced skin injury. Sprague-Dawley rats were divided into five groups: a control group not receiving Zn, GH, or irradiation: a radiation (RT) group receiving a single 30 Gy dose of gamma irradiation to the right hind legs; a radiation + GH group (RT + GH) receiving a single 30 Gy dose of gamma irradiation plus the subcutaneous administration of 0.01 IU kg d-1 GH; a radiation + Zn group (RT + Zn) receiving a single 30 Gy dose plus 5 mg kg d-1 Zn po; and a radiation + GH + Zn group (RT + GH + Zn) group receiving a single 30 Gy dose plus subcutaneous 0.01 IU kg d-1 GH and 5 mg kg d-1 Zn po. Acute skin reactions were assessed every 3 days by two radiation oncologists grouping. Light microscopic findings were assessed blindly by two pathologists. Groups receiving irradiation were associated with dermatitis as compared to the control group (P < 0.05). The severity of radiodermatitis in the RT + GH, RT + Zn, and RT + GH + Zn groups was significantly lower than that in the RT group (P < 0.05). Furthermore, radiodermatitis was observed earlier in the RT group than in the other treatment groups (P < 0.05). GH and Zn effectively prevented epidermal atrophy, dermal degeneration, and hair follicle atrophy. The highest level of protection against radiation dermatitis was observed in the combination group.


Subject(s)
Disease Models, Animal , Gamma Rays , Growth Hormone/pharmacology , Radiodermatitis/prevention & control , Zinc Sulfate/pharmacology , Animals , Double-Blind Method , Growth Hormone/administration & dosage , Male , Rats , Rats, Sprague-Dawley , Zinc Sulfate/administration & dosage
3.
Breastfeed Med ; 11: 474-478, 2016 11.
Article in English | MEDLINE | ID: mdl-27673412

ABSTRACT

AIM: The aims of this study were to investigate the effects of calcium at the same concentration as that found in human milk on the viability, proliferation, and adhesion of MCF-7 human breast ductal carcinoma cells by exposing them to calcium at the same frequency as in breastfeeding. MATERIALS AND METHODS: High-concentration calcium was applied for 30 minutes every 4 hours for 24, 48, and 72 hours. Cell proliferation and viability were measured using a hemocytometer and the MTT cell viability assay. The effects of calcium treatment were evaluated by a comparison among a multiple-, single-dose calcium treatment, and a control group. RESULTS: We show that calcium at the same concentration as that in milk caused a decrease in the number of cells but did not affect cell viability. CONCLUSIONS: The results of this study suggest that calcium caused a lowering of the number of cells from the luminal surface of the breast by triggering proliferation under the condition of fluidity. Calcium and fluidity together serve to eliminate breast cancer stem cells during the lactation period. Effects of the other components of milk can be analyzed by the new method developed in this study.


Subject(s)
Breast Neoplasms/pathology , Breast/drug effects , Breast/pathology , Calcium/analysis , Calcium/pharmacology , Milk, Human/chemistry , Breast Feeding , Calcium/administration & dosage , Cell Adhesion/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Female , Humans , Lactation , MCF-7 Cells , Pregnancy
4.
Exp Ther Med ; 7(5): 1285-1290, 2014 May.
Article in English | MEDLINE | ID: mdl-24940426

ABSTRACT

Metformin is a guanidine derivative found in Galega officinalis that is commonly used to treat diabetes mellitus. The mechanism of action of metformin involves regulation of the adenosine monophosphate-activated protein kinase/mammalian target of rapamycin signaling pathway, which is implicated in the control of protein synthesis and cell proliferation. This led to the hypothesis that metformin reduces the risk of cancer and slows tumor growth. Thus, in the present study, the effectiveness of metformin as an antiglioma agent was evaluated using the human T98G glioblastoma multiforme cell line. The viability of the T98G cells was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptosis was monitored by measuring caspase-3 levels, as well as by terminal deoxynucleotidyl transferase dUTP nick end labeling and staining with acridine orange and ethidium bromide. The results demonstrate that metformin reduced cell viability and caused apoptotic morphological changes in the T98G cells. Furthermore, the caspase-3 levels in the metformin-treated T98G cells were higher than those in the control cells. Metformin induced apoptosis in the T98G cell line in a concentration-dependent manner. Metformin may provide an important contribution to the treatment of glioblastoma multiforme.

5.
J Enzyme Inhib Med Chem ; 27(4): 587-94, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21883037

ABSTRACT

In the present study, apoptotic, antioxidant and antiradical effects of majdine and isomajdine from Vinca herbacea Waldst. and Kit were studied. For testing the possible apoptotic effects of majdine and isomajdine from V. herbacea, DNA fragmentation assay was conducted on the rat brain cortical tissue homogenates, in vitro. Also their possible effects on mitochondrial activity were tested by using the same tissue samples of rats. In addition, the antioxidant activity of isomajdine and majdine was determined using various in vitro antioxidant assays, including 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS(•+)) radical scavenging and N,N-dimethyl-p-phenylenediamine (DMPD(•+)) radical scavenging, ferric ions (Fe(3+)) and cupric ions (Cu(2+)) reducing abilities and ferrous ions (Fe(2+)) chelating activity. On the other hand, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), α-tocopherol and trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) were used as reference antioxidants.


Subject(s)
Antioxidants/pharmacology , Apocynaceae/chemistry , Apoptosis/drug effects , Vinca Alkaloids/pharmacology , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Free Radical Scavengers/chemistry , Male , Mitochondria/drug effects , Mitochondria/metabolism , Molecular Structure , Oxidation-Reduction , Oxindoles , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship , Vinca Alkaloids/chemistry , Vinca Alkaloids/isolation & purification
6.
J Enzyme Inhib Med Chem ; 25(1): 44-53, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20030508

ABSTRACT

In the present study, we determined the antioxidant activity of cepharanthine and fangchinoline from Stephania rotunda by performing different in vitro antioxidant assays, including 1,1-diphenyl-2-picryl-hydrazyl (DPPH) free radical scavenging, 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) radical scavenging, N,N- dimethyl-p-phenylenediamine dihydrochloride (DMPD) radical scavenging, superoxide anion (O2*-) radical scavenging, hydrogen peroxide scavenging, total antioxidant activity, reducing power, and ferrous ion (Fe2+) chelating activities. Cepharanthine and fangchinoline showed 94.6 and 93.3% inhibition on lipid peroxidation of linoleic acid emulsion at 30 microg/mL concentration, respectively. On the other hand, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), alpha-tocopherol, and trolox indicated inhibitions of 83.3, 92.2, 72.4, and 81.3% on peroxidation of linoleic acid emulsion at the same concentration (30 microg/mL), respectively. According to the results, cepharanthine and fangchinoline have effective antioxidant and radical scavenging activity.


Subject(s)
Antioxidants/pharmacology , Benzylisoquinolines/pharmacology , Stephania/chemistry , Butylated Hydroxyanisole/pharmacology , Butylated Hydroxytoluene/pharmacology , Chromans/pharmacology , Lipid Peroxidation/drug effects , alpha-Tocopherol/pharmacology
7.
Int J Neurosci ; 119(10): 1602-14, 2009.
Article in English | MEDLINE | ID: mdl-19922377

ABSTRACT

In the present study, dantrolene, nimodipine, basilen blue, and ruthenium red were tested in experimental bilirubin toxicity in cortical cell culture of rats. Neurotoxicity was induced by 10(-4) M bilirubin. Basilen blue in the highest concentration of 10(-4) M was determined as the most protective agent when applied alone. Dantrolene alone was found surprisingly ineffective in all doses tested. But it was found very protective both in double and triple combinations. Nimodipine, basilen blue, and ruthenim red neuroprotective potentials were enhanced by adding dantrolene into the media. Best double combination was determined as dantrolene plus ruthenium red. On the other hand, most useful triple combination was found as dantrolene plus nimodipine plus basilen blue. As a result, dantrolene wasn't found to be effective alone, while it seems most potential compound in combined application in bilirubin-induced neurotoxicity. The importance of calcium intrusion was confirmed in bilirubin-induced neurotoxicity.


Subject(s)
Calcium Channel Blockers/pharmacology , Dantrolene/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Nimodipine/pharmacology , Ruthenium Red/pharmacology , Animals , Animals, Newborn , Antioxidants/toxicity , Bilirubin/toxicity , Cell Death/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Dose-Response Relationship, Drug , Drug Combinations , Drug Interactions , Neurons/physiology , Rats , Rats, Sprague-Dawley
8.
Int J Neurosci ; 119(10): 1705-17, 2009.
Article in English | MEDLINE | ID: mdl-19922382

ABSTRACT

In the present study we investigated the effects of mixed imidazoline-1 and alpha(2)-adrenoceptor agonist, moxonidine, in glutamate-induced neurotoxicity in frontal cortical cell cultures of rat pups by dye exclusion test. Also, phosphorylated p38 mitogen activated protein kinases (p-p38 MAPK) levels were determined from rat frontal cortical tissue homogenates by two dimensional gel electrophoresis and semidry western blotting. Glutamate at a concentration of 10(-6) M was found neurotoxic when applied for 16 hr in cell cultures. Dead cell mean scores were 12.8 +/- 0.5 for control and 52.3 +/- 4.8 for glutamate (p < .001). On the other hand, p-p38 MAPK levels start to increase at a glutamate concentration of 10(-7) M for 20 min application. Moxonidine was found to have an U-shape neuroprotective effect in glutamate-induced neurotoxicity in neuronal cell culture experiments. Even though moxonidine did not induce neurotoxicity alone between the doses of 10(-8) to 10(-4) M concentrations in cell culture series, it caused the reduction of glutamate-induced dead cell population 23.07 +/- 3.6% in 10(-6) M and 26.7 +/- 2.1% in 10(-5) M concentrations (p <.001 for both, in respect to control values). The protective effect of moxonidine was confirmed in 10(-8) and 10(-7) M, but not in higher concentrations in glutamate neurotoxicity in gel electrophoresis and western blotting of p-p38 MAPK levels. In addition to other studies that revealed an antihypertensive feature of moxonidine, we demonstrated a possible partial neuroprotective role in lower doses for it in glutamate-mediated neurotoxicity model.


Subject(s)
Imidazoles/pharmacology , Imidazoles/therapeutic use , Imidazoline Receptors/agonists , Neurons/drug effects , Neuroprotective Agents/pharmacology , Neurotoxicity Syndromes , Animals , Animals, Newborn , Cell Count/methods , Cells, Cultured , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions , Frontal Lobe/cytology , Gene Expression Regulation, Enzymologic/drug effects , Glutamic Acid/toxicity , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/drug therapy , Neurotoxicity Syndromes/enzymology , Neurotoxicity Syndromes/etiology , Rats , Rats, Sprague-Dawley , p38 Mitogen-Activated Protein Kinases/metabolism
9.
Neurosurg Rev ; 31(2): 205-13; discussion 213, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18259790

ABSTRACT

Our aim was to determine the effects of vitamin E and L-carnitine supplementation, individually or in combination, on radiation-induced brain and retinal damages in a rat model. Group 1 received no treatment (control arm). Group 2 received a total dose of 15 Gy external radiotherapy (RT) to whole brain by Cobalt-60 teletherapy machine. Groups 3, 4, and 5 received irradiation plus 40 kg(-1) day(-1) Vitamin E or 200 mg kg(-1)day(-1) L-carnitine alone or in combination. Brain and retinal damages were histopathologically evaluated by two independent pathologists. Antioxidant enzyme levels were also measured. Radiation significantly increased brain and retinal damages. A significant increase in malondialdehyde levels as well as a decrease in superoxide dismutase and catalase enzymes in brain was found in group 2. Separate administration of Vitamin E+RT and L-carnitine+RT significantly reduced the severity of brain and retinal damages and decreased the malondialdehyde levels and increased the activity of superoxide dismutase and catalase enzymes in the brain. The findings of current study support the antioxidant and radioprotective roles of vitamin E and L-carnitine. However, the combined use of Vitamin E and L-carnitine plus irradiation interestingly did not exhibit an additive radioprotective effect.


Subject(s)
Antioxidants/therapeutic use , Brain Injuries/prevention & control , Carnitine/therapeutic use , Radiation Injuries, Experimental/prevention & control , Retina/injuries , Vitamin E/therapeutic use , Animals , Antioxidants/metabolism , Brain/pathology , Brain Chemistry/drug effects , Brain Chemistry/radiation effects , Brain Injuries/pathology , Catalase/metabolism , Drug Therapy, Combination , Male , Malondialdehyde/metabolism , Radiation Injuries, Experimental/pathology , Rats , Rats, Sprague-Dawley , Retina/pathology , Superoxide Dismutase/metabolism
10.
Graefes Arch Clin Exp Ophthalmol ; 245(4): 588-94, 2007 Apr.
Article in English | MEDLINE | ID: mdl-16915402

ABSTRACT

BACKGROUND: The objective was to determine the antioxidant role of L-carnitine (LC) against ionizing radiation-induced cataracts in lens after total cranium irradiation of rats with a single dose of 5 Gy. METHODS: Sprague-Dawley rats were used in this experiment and were divided into three groups. Group 1 did not receive LC or irradiation (control group). Group 2 received a 5 Gy gamma irradiation as a single dose to the total cranium (RT group). Group 3 received total cranium irradiation plus 100 mg/kg body weight/day LC (RT+LC group). The rats were irradiated using a cobalt-60 teletherapy unit. At the end of the 10th day, the rats were sacrificed and their eyes were enucleated. The lenticular activity of the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were measured. Furthermore, the lenticular content of an indicator of lipid peroxidation, malondialdehyde (MDA), was measured. RESULTS: Irradiation significantly increased the MDA level as an end product of lipid peroxidation. Irradiation also significantly decreased SOD activity and increased GSH-Px activity, indicating the generation of oxidative stress and an early protective response to oxidative damage. Irradiation with 5 Gy to the total cranium as a single fraction formed cataracts in the rat lenses. Cataract development was detectable in 9 rats in the RT group, and in only 4 rats in the RT+LC group 10 days after irradiation. LC administration plus irradiation significantly decreased the MDA level and increased the activity of SOD and GSH-Px enzymes, which might indicate the protection of the lenses from gamma radiation-induced cataracts. CONCLUSIONS: L-carnitine may protect against the damage produced by gamma radiation by increasing the activity of the SOD enzyme and by scavenging free radicals generated by ionizing radiation. As a result of this process, MDA as an indicator of lipid peroxidation may decrease.


Subject(s)
Carnitine/pharmacology , Cataract/prevention & control , Gamma Rays , Lens, Crystalline/radiation effects , Radiation Injuries, Experimental/prevention & control , Vitamin B Complex/pharmacology , Animals , Cataract/enzymology , Cranial Irradiation , Disease Models, Animal , Female , Free Radical Scavengers , Glutathione Peroxidase/metabolism , Lens, Crystalline/enzymology , Lipid Peroxidation , Malondialdehyde/metabolism , Oxidative Stress , Radiation Injuries, Experimental/enzymology , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism
11.
Int J Vitam Nutr Res ; 77(5): 336-40, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18453318

ABSTRACT

In the present study, the possible protective effect of the pyridoxine against glutamate-induced neurotoxicity in cerebellar granular cell culture of rat pups is investigated for its therapeutic potential. Glutamate (10(-7) M) was administered to cerebellar granular cell cultures that were prepared from one-day-old Sprague-Dawley rats. The neuroprotective effect of pyridoxine was examined. Pyridoxine at the doses of 10(-8), 10(-7), 10(-6), and 10(-5) M was introduced into the culture flasks before inclusion of glutamate. Pyridoxine at the doses of 10(-8) M and 10(-7) M significantly reduced glutamate cytotoxicity. A 10(-7) M dose of pyridoxine proved to be more effective than a 10(-8) M dose. The present study demonstrates that pyridoxine may protect glutamate-induced neurotoxicity. Neuroprotective effect of pyridoxine, at least in part, may result from its anti-glutamatergic activity. Pyridoxine merits further investigation as a therapeutic option in hypoxic-ischemic brain injury.


Subject(s)
Glutamic Acid/toxicity , Neuroprotective Agents/pharmacology , Neurotoxicity Syndromes/prevention & control , Pyridoxine/pharmacology , Vitamin B Complex/pharmacology , Animals , Cell Culture Techniques , Cerebellum/drug effects , Dose-Response Relationship, Drug , Glutamic Acid/administration & dosage , Rats , Rats, Sprague-Dawley
12.
Brain Dev ; 28(7): 436-9, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16516423

ABSTRACT

There is growing evidence that glutamate receptor-mediated injury plays a crucial role in bilirubin neurotoxicity. L-carnitine (LC) has been shown to prevent glutamate-induced toxicity in neuronal cell culture. The purpose of this study is to assess whether LC is able to prevent bilirubin neurotoxicity. Unconjugated bilirubin at different concentrations was administered to cerebellar granular cell cultures prepared from 1-day-old Sprague-Dawley rats. The neuroprotective effect of LC was examined. LC at doses of 10(-6), 10(-5), 10(-4) and 10(-3) M was applied to culture flasks. LC at a dose of 10(-4) M significantly blocked bilirubin neurotoxicity. On the other hand, LC significantly increased bilirubin toxicity at a higher dose (10(-3) M). LC at the doses of 10(-5) and 10(-6) M was found to be ineffective. 10(-4) M LC decreased bilirubin-induced neuronal cell death from 47.72+/-3.68 to 27.23+/-5.14%, (P=0.003). The present study demonstrates, for the first time, that LC protects against bilirubin neurotoxicity in a dose-dependent manner in cerebellar granular cell culture of rats. Further research is needed to confirm our findings and to clarify the mechanisms responsible for the protective effect of LC.


Subject(s)
Bilirubin/toxicity , Carnitine/pharmacology , Neurons/drug effects , Vitamin B Complex/pharmacology , Animals , Animals, Newborn , Cell Count/methods , Cell Death/drug effects , Cells, Cultured , Cerebellum/cytology , Dose-Response Relationship, Drug , Drug Interactions , Rats , Rats, Sprague-Dawley
13.
Phytother Res ; 20(2): 130-4, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16444666

ABSTRACT

The antioxidant activity of a triterpenoid glycoside [3-O-(beta-D-glucopyranosyl)-hederagenin; OGH] isolated from the berries of Hedera colchica, an ivy species endemic in Georgia, was investigated. The antioxidant properties of OGH were evaluated using different antioxidant assays: 1,1-diphenyl-2-picryl-hydrazyl free radical (DPPH.) scavenging, total antioxidant activity, reducing power, superoxide anion radical (O2*-)) scavenging, hydrogen peroxide (H2O2) scavenging and metal chelating activities. The total antioxidant activity was measured according to the ferric thiocyanate method. alpha-Tocopherol and trolox, a water-soluble analogue of tocopherol, were used as reference antioxidant compounds. At a 30 microg/mL concentration, the inhibitory effects of OGH on the peroxidation of linoleic acid emulsion was found to be 95.3%, whereas alpha-tocopherol and trolox exhibited 88.8% and 86.2% inhibition of peroxidation in the system, respectively. In addition, OGH had effective DPPH. scavenging, superoxide anion radical scavenging, hydrogen peroxide scavenging, total reducing power and metal chelation of ferrous ions activities. These various antioxidant activities were compared with alpha-tocopherol and trolox.


Subject(s)
Antioxidants/pharmacology , Hedera/chemistry , Oleanolic Acid/analogs & derivatives , Saponins/pharmacology , Antioxidants/isolation & purification , Biphenyl Compounds , Fruit/chemistry , Iron Chelating Agents/pharmacology , Molecular Structure , Oleanolic Acid/isolation & purification , Oleanolic Acid/pharmacology , Picrates , Reducing Agents/pharmacology , Saponins/isolation & purification
14.
Brain Dev ; 27(8): 570-3, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16310592

ABSTRACT

Glutamate mediated intracellular calcium accumulation and free radical generation are thought to be major mechanisms that contribute to cell death in hypoxic-ischemic brain injury. For this reason, various glutamate receptor antagonists and antioxidants have been investigated for their therapeutic potential. To assess whether L-carnitine, a possible antioxidant, is able to prevent glutamate- and kainic acid (KA)-induced neurotoxicity. Glutamate (10(-7) M) and one of its receptor agonists, KA (10(-4) M) were administered to cerebellar granular cell cultures that were prepared from 1-day-old Sprague-Dawley rats. The neuroprotective effect of L-carnitine was examined. L-carnitine at doses of 10(-6), 10(-5), 10(-4), 10(-3) M was applied to culture flasks. L-carnitine at doses of 10(-4) and 10(-3) M significantly blocked glutamate-induced neurotoxicity. 10(-4) M dose of L-carnitine proved to be more effective than 10(-3)M. L-carnitine also blocked KA-induced neurotoxicity only at the dose of 10(-4) M. 10(-4) M L-carnitine, the most effective dose in both glutamate- and KA-induced neurotoxicity, decreased glutamate-induced neuronal cell death from 36.14+/-2.95% to 17.59+/-2.25%; (P<0.001) and KA-induced neuronal cell death from 21.4+/-0.41 to 13.4+/-1.38%; (P<0.001). The present study demonstrates that L-carnitine protects against glutamate- and KA-induced neurotoxicity. Protective effect of L-carnitine may result from its antioxidant activity because free radical generation is a common result in either glutamate- or KA-induced neurotoxicity. L-carnitine merits further investigation as a therapeutic option in hypoxic-ischemic brain injury of newborn.


Subject(s)
Carnitine/pharmacology , Cerebellum/drug effects , Glutamic Acid/metabolism , Kainic Acid/metabolism , Neuroprotective Agents/pharmacology , Neurotoxins/metabolism , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Carnitine/therapeutic use , Cell Death/physiology , Cells, Cultured , Cerebellum/cytology , Cerebellum/metabolism , Hypoxia-Ischemia, Brain/drug therapy , Neuroprotective Agents/therapeutic use , Rats , Rats, Sprague-Dawley
15.
Pharmacogenet Genomics ; 15(9): 609-24, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16041240

ABSTRACT

The human cytochrome P450 2A6 (CYP2A6) enzyme metabolizes several xenobiotic compounds of clinical or toxicological importance. We aimed to identify genetic variants and major CYP2A6 haplotypes associated with CYP2A6 phenotypic variation. CYP2A6 mRNA level, protein level, activity and haplotypes were determined in Caucasian liver samples via real-time polymerase chain reaction, Western blot, coumarin 7-hydroxylation, DNA sequencing and genotyping, respectively. Phenotypes were then analyzed for associations with haplotypes. CYP2A6 transcript, protein and activity levels were correlated among each other. In 45 African-American, 156 Caucasian, 47 Chinese, 50 Japanese and 47 Korean DNA samples, we detected 95 different polymorphisms in the CYP2A6 gene, 49 of which had not been described previously. Caucasian variants formed 33 haplotypes which built four clades. Allele *9B and the CYP2A7/2A6 partial deletion allele CYP2A6*12B were both associated with decreased expression. The latter haplotype extends at least over 147 kb up into the CYP2B6 gene. A haplotype almost identical to allele *1A was associated with decreased expression and activity of CYP2A6 compared to all other haplotypes. In summary A CYP2A6*1A-like allele, *9B and *12B are major genetic determinants of CYP2A6 phenotype variation in Caucasians.


Subject(s)
Aryl Hydrocarbon Hydroxylases/genetics , Aryl Hydrocarbon Hydroxylases/metabolism , Mixed Function Oxygenases/genetics , Mixed Function Oxygenases/metabolism , Alleles , Apolipoproteins/chemistry , Base Sequence , Blotting, Western , Cloning, Molecular , Coumarins/pharmacology , Cytochrome P-450 CYP2A6 , DNA/metabolism , DNA Primers/chemistry , DNA, Complementary/metabolism , Exons , Gene Deletion , Genetic Variation , Genotype , Haplotypes , Humans , Liver/metabolism , Models, Genetic , Molecular Sequence Data , Phenotype , Polymorphism, Genetic , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid , White People , Xenobiotics
16.
J Radiat Res ; 46(2): 277-82, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15988147

ABSTRACT

One of the mechanisms proposed to explain lens opacification is the oxidation of crystallins, either by radiation or reactive oxygen species (ROS). It has been shown that melatonin has both an anti-peroxidative effect on several tissues and a scavenger effect on ROS. The purpose of this study was to determine the antioxidant role of melatonin (5 mg/kg/day) against radiation-induced cataract in the lens after total-cranium irradiation of rats with a single dose of 5 Gy. Sprague-Dawley rats were divided into four groups. Control group received neither melatonin nor irradiation. Irradiated rats (IR) and melatonin+irradiated rats (IR+Mel) groups were exposed to total cranium irradiation of 5 Gy in a single dose by using a cobalt-60 teletherapy unit. IR+Mel and melatonin (Mel) groups were administered 5 mg/kg melatonin daily by intraperitoneal injections during ten days. Chylack's cataract classification was used in this study. At the end of the 10th day, the rats were killed and their eyes were enucleated to measure the antioxidant enzymes i.e. the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and lipid peroxidation level (malondialdehyde (MDA)). Irradiation significantly increased the MDA level, as an end product of lipid peroxidation, and also significantly decreased SOD and GSH-Px activity, emphasizing the generation of increased oxidative stress. Rats injected with melatonin only did not cause cataract formation. Melatonin supplementation with irradiation significantly increased the activity of SOD and GSH-Px enzymes and significantly decreased the MDA level. Total cranium irradiation of 5 Gy in a single dose enhanced cataract formation, and melatonin supplementation protected the lenses from radiation-induced cataract formation. Our results suggest that supplementing cancer patients with adjuvant therapy of melatonin may reduce patients suffering from toxic therapeutic regimens such as chemotherapy and/or radiotherapy and may provide an alleviation of the symptoms due to radiation-induced organ injuries.


Subject(s)
Antioxidants/metabolism , Cataract/metabolism , Cataract/prevention & control , Heavy Ions/adverse effects , Melatonin/administration & dosage , Radiation Injuries/metabolism , Radiation Injuries/prevention & control , Radiation-Protective Agents/administration & dosage , Animals , Cataract/etiology , Cataract/pathology , Disease Models, Animal , Female , Free Radical Scavengers/administration & dosage , Injections, Intraperitoneal , Radiation Injuries/pathology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Treatment Outcome
17.
J Ethnopharmacol ; 101(1-3): 287-93, 2005 Oct 03.
Article in English | MEDLINE | ID: mdl-15964162

ABSTRACT

The purpose of this work comprise the assessment of the antioxidant activity of total anthocyanins from Perilla pankinensis samples (TAPP) by different analytical methods: 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging, total antioxidant activity, total reducing activity, superoxide anion radical scavenging, hydrogen peroxide scavenging and metal chelating activities. Total antioxidant activity was measured according to ferric thiocyanate method. alpha-Tocopherol and trolox, which water-soluble analogue of tocopherol were used as references antioxidant compounds. At the concentrations of 30 and 45 microg/mL, TAPP showed 91.9 and 96.4% inhibition on lipid peroxidation of linoleic acid emulsion, respectively. In comparison, 45 microg/mL of standard antioxidant such as alpha-tocopherol and trolox exhibited 88.8 and 86.2% inhibition on peroxidation of linoleic acid emulsion, respectively. In addition, TAPP have found effective on DPPH scavenging, superoxide anion radical and hydrogen peroxide scavenging, total reducing power and metal chelating on ferrous ions activities. Also, these various antioxidant effects were compared to alpha-tocopherol and trolox.


Subject(s)
Anthocyanins/pharmacology , Antioxidants/pharmacology , Free Radical Scavengers/pharmacology , Perilla/chemistry , Biphenyl Compounds/metabolism , Hydrazines/metabolism , Picrates , Superoxides/metabolism
18.
Toxicol In Vitro ; 19(5): 589-94, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15896552

ABSTRACT

In the present study, we used the L-type calcium channel blocker nimodipine, the endoplasmic reticulum (ER) calcium release blocker dantrolene and the calcium transport blocker in mitochondria ruthenium red (RuR), in NMDA induced neurotoxicity, to observe the most suitable combination for neuroprotection in cerebellar granular cell culture of rat pups. In addition we tested the effect of RuR on intact neuronal cells without adding NMDA into the flask, in order to compare the effects. As was expected, NMDA induced neuronal cell death. In NMDA induced neurotoxicity, RuR was the most neuroprotective agent of all three compounds tested, but interestingly, RuR alone was found to be neurotoxic in non-NMDA treated cultures. RuR showed neuroprotectivity in a dose dependent manner in NMDA toxicity. Dantrolene and nimodipine were also found to have neuroprotective properties in NMDA induced cell death in rat cerebellum. On the other hand, the combined application of the compounds was not found as protective as ruthenium red applications alone. The present study revealed a neurotoxic feature of ruthenium red, however we also demonstrated a neuroprotective role for it in NMDA-mediated neuron culture. This could be interpreted as a result of the partial agonistic effect of ruthenium red.


Subject(s)
Cerebellum/drug effects , Dantrolene/pharmacology , N-Methylaspartate/toxicity , Neuroprotective Agents/pharmacology , Neurotoxicity Syndromes/prevention & control , Nimodipine/pharmacology , Ruthenium Red/pharmacology , Animals , Calcium/metabolism , Cells, Cultured , Cerebellum/cytology , Rats , Rats, Sprague-Dawley
19.
Int J Neurosci ; 115(1): 13-21, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15768848

ABSTRACT

Caffeine is widely spread and well known as a mild stimulant of the central nervous system. The present study tested the role of caffeine and Ruthenium red on the intact neuronal cells alone and Ruthenium red in caffeine-induced neurotoxicity. One-day-old newborn rats were used to obtain cerebellar cell cultures. Caffeine at a concentration of 1 mM was found to be most toxic. Dead cell scores were 5.9 +/- 0.8 for control, and 56.2 +/- 3.4 for caffeine (p < .001). Ruthenium red alone has also caused the reduction in neuronal cell number 36.1 +/- 4.5 for 10(-5) and 47 +/- 2.7 for 10(-6) M concentrations (p < .001 for both). Interestingly Ruthenium red used in caffeine-induced neurotoxicity has partly diminished the number of dead cells 28.7 +/- 3.2 for 10(-5) and 23.8 +/- 2.27 for 10(-6) M concentrations (p < .001for both). The results suggest that both Ruthenium red and caffeine are neurotoxic alone but, in combination, the neurotoxicity may be reduced through partial agonistic action.


Subject(s)
Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Cerebellum/cytology , Indicators and Reagents/pharmacology , Neurons/drug effects , Ruthenium Red/pharmacology , Analysis of Variance , Animals , Animals, Newborn , Cell Count , Cell Death/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Interactions , Neurons/physiology , Rats
20.
Int J Neurosci ; 115(2): 245-53, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15764004

ABSTRACT

Neurotoxicity induced by caffeine in auditory-neuron cultures was studied in rat pups. For possible protective effect, reactive blue (RB) alone and in combination with dantrolene were tested in subsequent doses. RB was found to have a U-shape neuroprotective effect in caffeine neurotoxicity. Dantrolene was also tested in combined application in caffeine neurotoxicity. Despite the existing neuroprotection, no additional protection was obtained with various doses of dantrolene. In conclusion, RB may exert neuroprotective effect by increasing intracellular ATP levels in caffeine toxicity. High ATP levels may postpone the toxic cascade. Dantrolene as an endoplasmic reticulum calcium release blocker had no additional protective effect, suggesting that the increased intracellular calcium levels may be involved in later states of the toxic cascade, occurring after the compensatory phase of the cell death.


Subject(s)
Auditory Cortex/drug effects , Caffeine/adverse effects , Caffeine/antagonists & inhibitors , Calcium Channels/drug effects , Calcium Channels/metabolism , Central Nervous System Stimulants/adverse effects , Central Nervous System Stimulants/antagonists & inhibitors , Intracellular Space/metabolism , Neuroprotective Agents/pharmacology , Triazines/pharmacology , Animals , Animals, Newborn , Auditory Cortex/pathology , Caffeine/administration & dosage , Cell Culture Techniques , Central Nervous System Stimulants/administration & dosage , Dantrolene/administration & dosage , Dantrolene/pharmacology , Drug Administration Schedule , Drug Combinations , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/administration & dosage , Rats , Rats, Sprague-Dawley , Triazines/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...